Human endothelial as well as epithelial cells were shown to respond to lipopolysaccharides (LPSs). However, the expression and release of CD14 by these so-called CD14-negative cells have not been studied in detail. We investigated three human intestinal epithelial cell lines (ECLs), SW-480, HT-29, and Caco-2, for their expression of CD14 and CD11c/CD18 as well as their responsiveness to endotoxins. Fluorescence-activated cell sorter analysis revealed no expression of CD11c/CD18, but there was low expression of membrane-bound CD14 on HT-29, Caco-2, and SW-480 ECLs. Both Western blotting and reverse transcription-PCR confirmed the CD14 positivity of all three intestinal ECLs. No substantial modulation of CD14 expression was achieved after 6, 8, 18, 24, and 48 h of cultivation with 10-fold serial dilutions of LPS ranging from 0.01 ng/ml to 100 microg/ml. Interestingly, soluble CD14 was found in the tissue culture supernatants of all three ECLs. Finally, only HT-29 and SW-480, and not Caco-2, cells responded to LPS exposure (range, 0.01 ng/ml to 100 microg/ml) by interleukin 8 release. Thus, we show that HT-29, SW-480, and Caco-2 human intestinal ECLs express membrane-bound CD14. As Caco-2 cells did not respond to LPS, these cell lines might be an interesting model for studying the receptor complex for LPS. The fact that human intestinal epithelial cells are capable not only of expression but also of release of soluble CD14 may have important implications in vivo, e.g., in shaping the interaction between the mucosal immune system and bacteria in the gut and/or in the pathogenesis of endotoxin shock.

Division of Immunology and Gnotobiology Institute of Microbiology Czech Academy of Sciences Vídenská 1083 142 20 Prague 4 Czech Republic

Erratum v

Infect Immun 2001 Aug;69(6):5216 PubMed

Zobrazit více v PubMed

Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, Miyake K. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4–MD-2. Biochem Biophys Res Commun. 2000;268:172–177. PubMed

Bažil V, Baudyš M, Hilgert I, Stefanová I, Low M G, Zbrozek J, Hořejší V. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol. 1989;26:657–662. PubMed

Bažil V, Strominger J L. Shedding as a mechanism of down-regulation of CD14 on stimulated human monocytes. J Immunol. 1991;147:1567–1574. PubMed

Cario E, Rosenberg I M, Brandwein S L, Beck P L, Reinecker H C, Podolsky D K. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 2000;164:966–972. PubMed

Cebecauer, M., J. Černý, and V. Hořejší. Incorporation of leucocyte GPI-anchored proteins and protein tyrosinc kinases into lipid-rich membrane domains of COS-7 cells. Biochem. Biophys. Res. Commun. 243:706–710. PubMed

Consentino G, Soprana E, Thienes C P, Siccardi A G, Viale G, Vercelli D. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol. 1995;15:3145–3151. PubMed

Dentener M A, Bažil V, von Asmuth E J U, Ceska M, Buurman W A. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-α, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol. 1993;150:2885–2891. PubMed

Diamond G, Russell J P, Bevins C L. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci USA. 1996;93:5156–5160. PubMed PMC

Duchow J, Marchant A, Crusiaux A, Husson C, Alonso-Vega C, De Groote D, Neve P, Goldman M. Impaired phagocyte response to LPS in paroxysmal nocturnal hemoglobinuria. Infect Immun. 1993;61:4280–4285. PubMed PMC

Eckmann I, Jung H C, Schurer-Maly C, Panja A, Morzycka-Wroblewska E, Kagnoff M F. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology. 1993;105:1689–1697. PubMed

Faure E, Equils O, Sieling P A, Thomas L, Zhang F X, Kirschning C J, Polentarutti N, Muzio M, Arditi M. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem. 2000;275:11058–11063. PubMed

Fearns C, Kravchenko V V, Ulevitch R J, Loskutoff D J. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med. 1995;181:857–866. PubMed PMC

Fearns C, Loskutoff D J. Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun. 1997;65:4822–4831. PubMed PMC

Fearns C, Ulevitch R J. Effect of recombinant interleukin-1beta on murine CD14 gene expression in vivo. Shock. 1998;9:157–163. PubMed

Ferrero E, Goyert S M. Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucleic Acids Res. 1988;16:4173. PubMed PMC

Frey E A, Miller D S, Jahr T G, Sundan A, Bažil V, Espevik T, Finlay B B, Wright S D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med. 1992;176:1665–1671. PubMed PMC

Fusunyan R D, Qinn J, Ohno Y, Richard P, MacDermott R P, Sanderson I R. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1beta and lipopolysaccharide. Pediatr Res. 1998;43:84–90. PubMed

Glauser M P, Zanetti G, Baumgartner J D, Cohen J. Septic shock: pathogenesis. Lancet. 1991;338:732–736. PubMed

Grimm M C, Pavli P, Van de Pol E, Doe W F. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa—implications for pathogenesis. Clin Exp Immunol. 1995;100:291–297. PubMed PMC

Grimm M C, Pullmann W E, Bennett G M, Sullivan P J, Pavli P, Doe W F. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol. 1995;10:387–395. PubMed

Hailman E, Lichenstein H S, Wurfel M M, Miller D S, Johnson D A, Kelley M, Busse L A, Zukowski M M, Wright S D. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med. 1994;179:269–277. PubMed PMC

Hailman E, Vasselon T, Kelley M, Busse L A, Hu M C, Lichenstein H S, Detmers P A, Wright S D. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol. 1996;156:4384–4390. PubMed

Haziot A, Rong G W, Silver J, Goyert S M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide J. Immunol. 1993;151:1500–1507. PubMed

Hořejší V, Drbal K, Cebecauer M, Ĉerný J, Brdička T, Angelisová P, Stockinger H. GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today. 1999;20:356–361. PubMed

Ingalls R R, Golenbock D T. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med. 1995;181:1473–1479. PubMed PMC

Kirschning C J, Wesche H, Ayers T M, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 1998;188:2091–2097. PubMed PMC

Labeta M O, Durieux J J, Spagnoli G, Fernandez N, Wijdenes J, Herrmann R. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology. 1993;80:415–423. PubMed PMC

Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. PubMed

Lammers K M, Jansen J, Bijlsma P B, Ceska M, Tytgat G N, Laboisse C L, van Deventer S J. Polarised interleukin 8 secretion by HT 29/19A cells. Gut. 1994;35:338–342. PubMed PMC

Lauener R P L, Goyert S M, Geha R S, Vercelll D. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol. 1990;20:2375–2381. PubMed

Lee J D, Kato K, Tobias P S, Kirkland T N, Ulevitch R J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med. 1992;175:1697–1705. PubMed PMC

Lien E, Means T K, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton M J, Oikawa M, Qureshi N, Monks B, Finberg R W, Ingalls R R, Golenbock D T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Investig. 2000;105:497–504. PubMed PMC

Loppnow H, Stelter F, Schonbeck U, Schluter C, Ernst M, Schutt C, Flad H D. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun. 1995;63:1020–1026. PubMed PMC

Marchant A, Duchow J, Delville J P, Goldman M. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur J Immunol. 1992;22:1663–1665. PubMed

Matsuura K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med. 1994;179:1671–1676. PubMed PMC

Meijssen M A, Brandwein S L, Reinecker H C, Bhan A K, Podolsky D K. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am J Physiol. 1998;274:G472–G479. PubMed

Molmenti E P, Ziambaras T, Perlmutter D H. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem. 1993;268:14116–14124. PubMed

Pugin J, Heumann D, Tomasz A, Kravchenko V, Akamatsu Y, Nishijama M, Glauser M P, Tobias P S, Ulevitch R J. CD14 is a pattern recognition receptor. Immunity. 1994;1:509–516. PubMed

Pugin J, Kravchenko V V, Lee J D, Kline L, Ulevitch R J, Tobias P S. Cell activation mediated by glycosylphosphatidylinositol-anchored transmembrane forms of CD14. Infect Immun. 1998;66:1174–1180. PubMed PMC

Pugin J, Schurer-Maly C C, Letureq D, Moriarty A, Ulevitch R J, Tobias P S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA. 1993;90:2744–2748. PubMed PMC

Read M A, Cordle S R, Veach R A, Carlisle C D, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA. 1993;90:9887–9891. PubMed PMC

Rogler G, Hausmann M, Spotti T, Vogi D, Aschenbrenner E, Andus T, Falk W, Scholmerich J, Gross V. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa. Eur J Gastroenterol Hepatol. 1999;11:1105–1111. PubMed

Salzman A L, Eaves-Pyles T, Linn S C, Denenberg A G, Szabó C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology. 1998;114:93–102. PubMed

Schroeder R A, delaTorre A, Kuo P C. CD14-dependent mechanism for endotoxin-mediated nitric oxide synthesis in murine macrophages. Am J Physiol. 1997;273:C1030–C1039. PubMed

Schumann R R, Rietschel E T. The role of CD14 and LBP in the activation of different cell types by endotoxin. Med Microbiol Immunol. 1994;183:279–297. PubMed

Smith P D, Janoff E N, Mosteller-Barnum M, Merger M, Orenstein J M, Kearney J F, Graham M F. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J Immunol Methods. 1997;202:1–11. PubMed

Sugawara S, Sugiyama A, Nemoto E, Rikiishi H, Takada H. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun. 1998;66:3043–3049. PubMed PMC

ter Steege J, Buurman W, Arends J W, Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Investig. 1997;77:29–36. PubMed

Ulevitch R J, Tobias P S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol. 1995;13:437–457. PubMed

Vita N, Lefort S, Sozzani P, Reeb R, Richards S, Borysiewicz L K, Ferrara P, Labeta M O. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol. 1997;158:3457–3462. PubMed

Von Asmuth E J U, Dentener M A, Bažil V, Bouma M G, Leeuwenberg J F M. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin. Immunology. 1993;80:78–83. PubMed PMC

Wright S D. Multiple receptors for endotoxin. Curr Opin Immunol. 1991;3:83–90. PubMed

Wright S D, Ramos R A, Hermanowski-Vosatka A, Rockwell P, Detmers P A. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med. 1991;173:1281–1286. PubMed PMC

Wright S D, Ramos R A, Tobias P S, Ulevitch R J, Mathison J. CD14, a receptor for complexes of LPS and LPS/binding protein. Science. 1990;249:1431–1433. PubMed

Yang R B, Mark M R, Gray A, Huang A, Xie M H, Zhang H, Goddard A, Wood W I, Gurney A L, Godowski P J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998;17:284–288. PubMed

Ziegler-Heitbrock H W, Ulevitch R J. CD14: cell surface receptor and differentiation marker. Immunol Today. 1993;14:121–125. PubMed

Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun J-L, Rousset M. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol. 1985;122:21–29. PubMed

Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD

Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate

Expression of IGF-1R and iNOS in nasal polyps; epithelial cell homeostasis and innate immune mechanisms in pathogenesis of nasal polyposis